Institutional Ownership
Nurix Therapeutics Inc
CUSIP 67080M103COMNRIXQ1 2026
13D / 13G Filings
57
Schedule 13D/13G on record
Beneficial Filers
22
Distinct reporting persons
Largest Stake
14.5%
Max % of class reported
Institutional Holders
188
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
57 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Baker Bros. Advisors LP | 13G/A | 7.2% | 7.53M | SEC |
| 2 | Nov 14, 2025 | Commodore Capital LP | 13G/A | 11.0% | 3.78M | SEC |
| 3 | Nov 7, 2025 | Fmr LLC | 13G/A | 4.1% | 4.16M | SEC |
| 4 | Nov 5, 2025 | Fmr LLC | 13G/A | 11.5% | 8.79M | SEC |
| 5 | May 15, 2025 | Deep Track Capital, LP | 13G/A | 7.2% | 5.50M | SEC |
| 6 | May 12, 2025 | Wellington Management Group LLP | 13G/A | 4.2% | 3.19M | SEC |
| 7 | May 12, 2025 | Fmr LLC | 13G/A | 13.4% | 10.25M | SEC |
| 8 | Apr 23, 2025 | Blackrock, Inc. | 13G/A | 8.2% | 6.28M | SEC |
| 9 | Feb 14, 2025 | Commodore Capital LP | 13G | 5.1% | 3.85M | SEC |
| 10 | Feb 14, 2025 | Deep Track Capital, LP | 13G | 5.4% | 4.13M | SEC |
47 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Nurix Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 8.93M | $138.35M |
| 2 | Redmile Group, LLC | 7.73M | $119.86M |
| 3 | Vestal Point Capital, LP | 6.50M | $100.75M |
| 4 | Deep Track Capital, LP | 6.35M | $98.35M |
| 5 | Fmr LLC | 5.54M | $85.89M |
| 6 | State Street Corp | 5.14M | $79.69M |
| 7 | Morgan Stanley | 4.93M | $76.45M |
| 8 | Baker Bros. Advisors LP | 4.66M | $72.21M |
| 9 | General Atlantic, L.P. | 4.10M | $63.58M |
| 10 | Perceptive Advisors LLC | 3.71M | $57.52M |